These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10719809)

  • 21. Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection.
    Komatsu H; Fujisawa T; Inui A; Miyagawa Y; Onoue M
    J Med Virol; 1997 Dec; 53(4):361-5. PubMed ID: 9407384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
    Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
    J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Koyama R; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Intervirology; 2007; 50(1):16-23. PubMed ID: 17164553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
    Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.
    Squadrito G; Leone F; Sartori M; Nalpas B; Berthelot P; Raimondo G; Pol S; Bréchot C
    Gastroenterology; 1997 Aug; 113(2):567-72. PubMed ID: 9247477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan.
    Lee CM; Hung CH; Lu SN; Wang JH; Tung HD; Huang WS; Chen CL; Chen WJ; Changchien CS
    Intervirology; 2006; 49(1-2):76-81. PubMed ID: 16166793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
    El-Shamy A; Shindo M; Shoji I; Deng L; Okuno T; Hotta H
    Hepatology; 2013 Aug; 58(2):555-63. PubMed ID: 23281009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients.
    Khorsi H; Castelain S; Wyseur A; Izopet J; Canva V; Rombout A; Capron D; Capron JP; Lunel F; Stuyver L; Duverlie G
    J Hepatol; 1997 Jul; 27(1):72-7. PubMed ID: 9252076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.
    Korba B; Shetty K; Medvedev A; Viswanathan P; Varghese R; Zhou B; Roy R; Makambi K; Ressom H; Loffredo CA
    J Gen Virol; 2015 Sep; 96(9):2928-2937. PubMed ID: 26296571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].
    López-Labrador FX; Ampurdanès S; Giménez-Barcons M; Guilera M; Costa J; Jiménez de Anta MT; Sánchez-Tapias JM; Rodés J; Sáiz JC
    Hepatology; 1999 Mar; 29(3):897-903. PubMed ID: 10051495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.
    Sakuma I; Enomoto N; Kurosaki M; Izumi N; Marumo F; Sato C
    J Infect Dis; 1999 Oct; 180(4):1001-9. PubMed ID: 10479124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method.
    Keskin F; Ciftci S; Akyuz F; Abaci N; Cakiris A; Akyuz U; Demir K; Besisik F; Ustek D; Kaymakoglu S
    Clin Lab; 2017 Sep; 63(9):1439-1445. PubMed ID: 28879707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.
    Hung CH; Chen CH; Lee CM; Wu CM; Hu TH; Wang JH; Yen YH; Lu SN
    J Viral Hepat; 2008 Jan; 15(1):58-65. PubMed ID: 18088246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNA.
    Akuta N; Suzuki F; Kobayashi M; Sezaki H; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
    J Clin Microbiol; 2015 Sep; 53(9):3039-41. PubMed ID: 26135874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Thélu MA; Leroy V; Ramzan M; Dufeu-Duchesne T; Marche P; Zarski JP
    J Med Virol; 2007 Mar; 79(3):242-53. PubMed ID: 17245718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon.
    Kim SK; Kim SR; Imoto S; Tohyama M; Otono Y; Tamura T; Kim KI; Kobayashi M; Ohtani A; Sugimoto K; Mizuguchi A; Hiramatsu Y; Kudo M
    Oncology; 2015; 89 Suppl 2():60-9. PubMed ID: 26584037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis.
    Murashima S; Ide T; Miyajima I; Kumashiro R; Ueno T; Sakisaka S; Sata M
    Scand J Infect Dis; 1999; 31(1):27-32. PubMed ID: 10381214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
    Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
    Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.